Increased peripheral blood T-cell apoptosis and decreased Bcl-2 in chronic obstructive pulmonary disease

Immunology and Cell Biology

Volumn 83, Issue 2, 2005, Pages 160-166

  Hodge, Sandra ^a   Hodge, Greg ^a,b   Holmes, Mark ^a   Reynolds, Paul N ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Apoptosis; Chronic obstructive pulmonary disease (COPD); Corticosteroid; Flow cytometry; T cell

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; CYTOKINE; FLUTICASONE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; LIPOCORTIN 5; PHYTOHEMAGGLUTININ; PREDNISOLONE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SALMETEROL; SINGLE STRANDED DNA;

ADULT; APOPTOSIS; ARTICLE; CELL STIMULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; STAINING; SYMPTOM; T LYMPHOCYTE;

AGED; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CYTOKINES; HUMANS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, CYTOKINE; T-LYMPHOCYTES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 16344363033     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2005.01317.x     Document Type: Article

References (37)

1. Bernard S, LeBlanc P, Whittom F et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 158: 629-34.
2. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am. J. Respir. Crit. Care Med. 1996; 154: 1055-60.
3. Kamischke A, Kemper DE, Castel MA et al. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur. Respir. J. 1998; 11: 41-5.
4. Lehmann C, Wilkening A, Leiber D et al. Lymphocytes in the bronchoalveolar space reenter the lung tissue by means of the alveolar epithelium, migrate to regional lymph nodes, and subsequently rejoin the systemic immune system. Anat. Rec. 2001; 264: 229-36.
5. Hodge SJ, Hodge GL, Reynolds PN, Scicchitano R, Holmes M. Increased production of TGF-beta and apoptosis of T lymphocytes isolated from peripheral blood in COPD. Am. J. Physiol Lung Cell Mol. Physiol. 2003; 285: L492-9.
6. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117: 684-94.
7. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med. 2001; 163: 737-44.
8. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur. Respir. J. 2001; 17: 946-53.
9. Loppow D, Schleiss MB, Kanniess F, Taube C, Jorres RA, Magnussen H. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir. Med. 2001; 95: 115-21.
10. Barnes PJ. Chronic obstructive pulmonary disease. N. Engl. J. Med. 2000; 343: 269-80.
11. Niewoehner DE, Erbland ML, Deupree RH et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 1999; 340: 1941-7.
12. Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am. J. Respir. Crit. Care Med. 1996; 154: 407-12.
13. Newell MK, Haughn LJ, Maroun CR, Julius MH. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 1990; 347: 286-9.
14. Vuorinen T, Peri P, Vainionpaa R. Measles virus induces apoptosis in uninfected bystander T cells and leads to granzyme B and caspase activation in peripheral blood mononuclear cell cultures. Eur. J. Clin. Invest. 2003; 33: 434-42.
15. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991; 51: 6304-311.
16. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 1995; 13: 513-43.
17. Hall PA, McKee PH, Menage HD, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993; 8: 203-207.
18. Rahman I, Swarska E, Henry M, Stolk J, MacNee W. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 2000; 55: 189-93.
19. Khaled AR, Kim K, Hofmeister R, Muegge K, Durum SK. Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc. Natl Acad. Sci. USA 1999; 96: 14 476-81.
20. Nelson BH, Willerford DM. Biology of the interleukin-2 receptor. Adv. Immunol. 1998; 70: 1-81.
21. Vella AT, Dow S, Potter TA, Kappler J, Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl Acad. Sci. USA 1998; 95: 3810-815.
22. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLB1/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 2001; 163: 1256-76.
23. Hodge G, Hodge S, Han P. Increased levels of apoptosis of leukocyte subsets in cultured PBMCs compared to whole blood as shown by Annexin V binding: relevance to cytokine production. Cytokine 2000; 12: 1763-8.
24. Hodge G, Han P. Factor VIII concentrate inhibits T helper type 2 cytokine production in vitro: relevance to inhibitor antibody formation. Haemophilia 2001; 7: 490-96.
25. Hodge GL, Flower R, Han P. Optimal storage conditions for preserving granulocyte viability as monitored by Annexin V binding in whole blood. J. Immunol. Methods 1999; 225: 27-38.
26. Hodge G, Han P. Effect of intermediate-purity factor VIII (FVIII) concentrate on lymphocyte proliferation and apoptosis: transforming growth factor-beta is a significant immunomodulatory component of FVIII. Br. J. Haematol. 2001; 115: 376-81.
27. Del Poeta G, Venditti A, Del Principe MI et al. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML). Blood 2003; 101: 2125-31.
28. Ong YL, McMullin MF, Bailie KE, Lappin TR, Jones FG, Irvine AE. High bax expression is a good prognostic indicator in acute myeloid leukaemia. Br. J. Haematol. 2000; 111: 182-9.
29. van Stijn A, Kok A, van der Pol MA et al. A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia. Leukemia 2003; 17: 780-86.
30. Yoshino T, Kishi H, Nagata T, Tsukada K, Saito S, Muraguchi A. Differential involvement of p38 MAP kinase pathway and Bax translocation in the mitochondria-mediated cell death in TCR- and dexamethasone-stimulated thymocytes. Eur. J. Immunol. 2001; 31: 2702-708.
31. Ayanlar Batuman O, Ferrero AP, Diaz A, Jimenez SA. Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. J. Clin. Invest. 1991; 88: 1574-80.
32. Boise LH, Minn AJ, Thompson CB. Receptors that regulate T-cell susceptibility to apoptotic cell death. Ann. N. Y. Acad. Sci. 1995; 766: 70-80.
33. Rathmell JC, Farkash EA, Gao W, Thompson CB. IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 2001; 167: 6869-76.
34. Sade H , Sarin A. IL-7 inhibits dexamethasone-induced apoptosis via Akt/PKB in mature, peripheral T cells. Eur. J. Immunol. 2003; 33: 913-19.
35. Yin Y, Terauchi Y, Solomon GG et al. Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature 1998; 391: 707-710.
36. Korsmeyer SJ, Yin XM, Oltvai ZN, Veis-Novack DJ, Linette GP. Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim. Biophys. Acta 1995; 1271: 63-6.
37. Chen W, Frank ME, Jin W, Wahl SM. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 2001; 14: 715-25.